Liliana Chicaíza
National University of Colombia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Liliana Chicaíza.
Biomedica | 2015
Mario García; Liliana Chicaíza; Hoover Quitian; Adriana Linares; Oscar Ramírez
INTRODUCTION Acute myeloid leukemia represents about 20% of leukemias in minors under 18 years old. At present, there are only two consolidation treatment alternatives: Chemotherapy and stem-cell transplantation. OBJECTIVE To evaluate the cost-effectiveness of unrelated and related hematopoietic stem cell transplantations, versus chemotherapy consolidation in pediatric patients with high-risk acute myeloid leukemia. MATERIALS AND METHODS A decision tree was constructed with life-years gained as the outcome. Costs and probabilities were extracted from the literature. Probabilistic sensitivity analyses and acceptability curves were computed. The cost-effectiveness threshold was three times the 2010 per capita gross domestic product. RESULTS When compared to consolidation chemotherapy cycles, related and unrelated hematopoietic stem-cell transplantation had incremental cost-effectiveness ratios of COP
Archive | 2013
Liliana Chicaíza; Mario García Molina; Giancarlo Romano
9,226,421 (USD
DOCUMENTOS DE TRABAJO - ESCUELA DE ECONOMÍA | 2010
Mario García Molina; Liliana Chicaíza; Oscar Gamboa
4,820) and COP
Archive | 2008
Liliana Chicaíza; Mario García Molina; Jaime Lozano
6,544,116 (USD
Biomedica | 2015
Mario García; Liliana Chicaíza; Hoover Quitian; Adriana Linares; Oscar Ramírez
3,419) respectively, which are lower than the per capita gross domestic product (COP
Biomedica | 2010
Oscar Gamboa; Sandra Díaz; Liliana Chicaíza; Mario García
12,047,418, USD
Revista de Economía Institucional | 2006
Liliana Chicaíza; Fredy Rodríguez; Mario García
6,294). Transplant proved to be cost-effective in 70% of the simulations and had a higher probability of the willingness to pay being over than COP
Value in Health | 2012
M. Garcia-Molina; Liliana Chicaíza; C.J. Rincon; G. Romano
7,200,000 (USD
Archive | 2012
Liliana Chicaíza; Mario García Molina; Sandra Oviedo; Carlos Rincón; Jorge Gómez Marín; Edith Ángel Muller; Jorge Andrés Rubio-Romero; Ingrid Arévalo; Pio Iván Gómez
3,762). CONCLUSION In Colombia, related and unrelated hematopoietic stem-cell transplants are cost-effective alternatives to consolidation treatment for high-risk acute myeloid leukemia in pediatric patients.
Innovar-revista De Ciencias Administrativas Y Sociales | 2008
Liliana Chicaíza; Ricardo Vega
Los años de vida ajustados por calidad – AVAC o QALY (en su sigla en inglés) – son una medida de resultados en salud que permite hacer comparaciones entre tratamientos con el fin de facilitar escogencias. A partir del desarrollo histórico de esta noción, se presenta su fundamento en las medidas de calidad de vida y en la teoría de utilidad esperada y los problemas derivados de los instrumentos de medición, en particular su fundamentación teórica, su facilidad de implementación y su falta de convergencia; también se presentan los problemas que deben ser tomados en cuenta para su estimación en Colombia específicamente en lo que tiene que ver con equidad y con la selección adecuada de muestra. Quality-adjusted life years – QALY – are a measure of health results that allows comparisons among treatments in order to make choices. Starting from the historical development of the concept, the paper presents its foundations in quality-of-life measures and in expected utility theory, as well as the problems arising from the measurement instruments, in particular their theoretical fundamentals, their implementability and their lack of convergence; it also presents the issues to be dealt with in their estimation for Colombia, with emphasis on those related to equality and the selection of an appropriate sample.